Navigation Links
Kwiksure and MSIG Comment on Recent Study on the Use of Mobile Phones While Driving
Date:8/26/2013

ry to distance themselves from any distractions as best as they can.”

It should be noted that Bhargava's and Pathania's study focused solely on the act of talking on the phone while driving, not sending or reading text messages or using other smart-phone functions.

Kwiksure experts are curious to see if the study will prompt any re-evaluations of current laws or beliefs regarding the use of mobile phones on the road. For the time-being, Kwiksure is still advising clients to refrain from using their mobile phones while operating their vehicles.

For more information, please visit http://www.kwiksure.com/news/mobile-phone-car-accident-study/.

Read the full story at http://www.prweb.com/releases/kwiksure-msig-comment/mobile-phone-driver-study/prweb11064060.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2

Related medicine news :

1. Recent Kwiksure Study Suggests Expat Drivers in Hong Kong More Likely to Make Traffic Accident Claims Than Locals
2. Hong Kong Insurers Unlikely to Lower Premiums for New Car Safety Technologies Says Kwiksure
3. Kwiksure Examines Why Drivers Have Fewer Accidents on Hong Kong Island than in the New Territories
4. Kwiksure Examines Relationship Between Health Insurance Coverage and Preventative Cancer Surgery
5. Kwiksure Discovers Uses and Limitations of Vehicle GPS in Hong Kong
6. Injury Law Firm Comments on the FDA Consumer Update Warning about Tylenol Side Effects like SJS
7. Voices Against Brain Cancer Comments on New Technique Being Used by Surgeons that Lights Up Brain Tumors
8. Steinger, Iscoe & Greene Comment on Cabbie Accident
9. Transvaginal Mesh Lawsuit Update: Rottenstein Law Group LLP Comments on Bard Mesh Trial Settlement in W. Va.
10. ObamacareMarketplace.com Announces: I. Mandate as a Featured Commentator
11. Flavor Your Life Comments on the Two Forms of Olive Oil Extraction
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/1/2015)... Tenn. (PRWEB) , ... July 01, 2015 , ... The ... held rain or shine Saturday, July 11, 2015, at 6 p.m. in Pugh Bourne ... free and includes pony rides, a petting zoo, an Elvis impersonator, a silent auction ...
(Date:7/1/2015)... Miami, Florida (PRWEB) , ... July 01, 2015 ... ... effects for society,” said lead author Lisa Stolzenberg, a Professor in FIU’s School ... on juveniles aged 12 to 17 years who participated in the National Survey ...
(Date:7/1/2015)... ... July 01, 2015 , ... Element Blue ™, ... today that it has received trademark protection for its SensorInsight® computer software platform. ... data from multiple sources providing an environment where users can view and compare ...
(Date:7/1/2015)... San Luis Obispo, CA (PRWEB) , ... July ... ... in non-surgical bunion treatment, announces their big summer sale. Customers purchasing two ... $15 with promo code "Summer15". , Bunion Bootie temporarily corrects misaligned ...
(Date:7/1/2015)... ... July 01, 2015 , ... ... healthcare providers, has been retained to lead a national chief executive officer ... executive search firms in the healthcare industry, B. E. Smith has recently placed ...
Breaking Medicine News(10 mins):Health News:Researchers find that medical marijuana laws increase recreational marijuana use among juveniles 2Health News:Element Blue Receives Trademark Protection from U.S. Patent and Trademark Office for Its Award Winning SensorInsight® Software 2Health News:Element Blue Receives Trademark Protection from U.S. Patent and Trademark Office for Its Award Winning SensorInsight® Software 3Health News:Element Blue Receives Trademark Protection from U.S. Patent and Trademark Office for Its Award Winning SensorInsight® Software 4Health News:Bunion Bootie, the #1 Non-Surgical Treatment for Bunion Pain, Announces Their Big Summer Sale 2Health News:Citizens Medical Center Retains B. E. Smith to Recruit New CEO 2Health News:Citizens Medical Center Retains B. E. Smith to Recruit New CEO 3
... Jan. 20 AXIOM Systems, Inc. (AXIOM), considered the ... release of products and services that assist organizations in the ... extensive testing of internal processes and external trading partner capabilities ... a larger challenge, to test the business impacts inherent in ...
... ... most advanced treatment options with an eye toward aesthetics, limiting visible scarring and focusing on ... ... opened a new office in Staten Island, offering comprehensive foot care with a focus on ...
... , Helping vulnerable children in aftermath of earthquake ... Given the chaos on the ground in Haiti , it ... children. , Because ChildFund does not operate in Haiti ... in Haiti for 30 years. This supports an established ...
... international multi-center clinical trial has found that acyclovir, a drug ... daily to suppress herpes simplex virus-2 (HSV-2), which is the ... risk of HIV transmission when taken by people infected with ... are published in the New England Journal of Medicine ...
... origin of osteogenesis imperfecta, researchers say , WEDNESDAY, Jan. ... a recessive form of brittle bone disease has been ... to be identified in a sequence of genes involved ... fatal genetic condition that weakens bones, resulting in frequent ...
... aid vaccine development, but could hinder efforts to eradicate ... -- Gorillas carry the parasite that causes malignant malaria ... to develop a vaccine for malaria, researchers say. , ... mosquitoes, most commonly in areas such as sub-Saharan Africa ...
Cached Medicine News:Health News:AXIOM Systems, Inc. Announces General Release of HIPAA 5010 Testing Solutions 2Health News:Park Avenue Podiatric Care Opens New Office in Staten Island Specializing in Cosmetic Foot Surgery 2Health News:Park Avenue Podiatric Care Opens New Office in Staten Island Specializing in Cosmetic Foot Surgery 3Health News:ChildFund Partners With Christian Blind Mission in Haiti 2Health News:ChildFund Partners With Christian Blind Mission in Haiti 3Health News:Herpes medication does not reduce risk of HIV transmission, UW-led international study finds 2Health News:Herpes medication does not reduce risk of HIV transmission, UW-led international study finds 3Health News:Herpes medication does not reduce risk of HIV transmission, UW-led international study finds 4Health News:New Gene ID'd in Brittle Bone Disease 2Health News:Malaria Parasite Infects Gorillas, Not Just Humans 2
(Date:7/1/2015)... 2015 Rock Creek Pharmaceuticals, Inc., (NASDAQ: ... inflammatory disease and neurologic disorders, announced today the results ... citrate, the Company,s lead compound. Results from the study ... can significantly inhibit the activation of inflammatory proteins in ... this compound in a Phase 1 clinical trial under ...
(Date:7/1/2015)... , July 1, 2015  BioPharmX Corporation (NYSE MKT: ... underwritten public offering of 3,636,364 shares of its common ... per share. BioPharmX has granted the underwriters a 30-day ... common stock at the public offering price. ... an existing stockholder, has agreed to purchase 1,081,081 shares ...
(Date:6/30/2015)... Scotland , July 1, 2015 ... joins Nu C ana team   ... ProTide technology to develop and commercialise a portfolio of ... Chris McGuigan as Chief Scientific Officer. ... ProTide technology. He is currently Professor of Medicinal Chemistry ...
Breaking Medicine Technology:Rock Creek Pharmaceuticals Reports Human Proof of Principle Study of Lead Compound Demonstrating Inhibition of Inflammatory Markers In White Blood Cells 2Rock Creek Pharmaceuticals Reports Human Proof of Principle Study of Lead Compound Demonstrating Inhibition of Inflammatory Markers In White Blood Cells 3Rock Creek Pharmaceuticals Reports Human Proof of Principle Study of Lead Compound Demonstrating Inhibition of Inflammatory Markers In White Blood Cells 4BioPharmX Corporation Closes Underwritten Public Offering of Common Stock 2BioPharmX Corporation Closes Underwritten Public Offering of Common Stock 3Internationally Renowned Medicinal Chemist Professor Chris McGuigan Appointed as NuCana's Chief Scientific Officer 2Internationally Renowned Medicinal Chemist Professor Chris McGuigan Appointed as NuCana's Chief Scientific Officer 3
... Amgen (Nasdaq: AMGN ), today announced the ... privately held biotechnology company based in Woburn, Mass., with ... a novel investigational oncolytic vaccine in Phase 3 clinical ... melanoma and head and neck cancer. The acquisition was ...
... , a leader in bioinformatics software and knowledge integration, ... license for Pathway Studio ® Enterprise system that ... MedScan® text processing technology for site-wide use. Pathway Studio ... pathways and develop mechanistic rationale for disease based on ...
Cached Medicine Technology:Amgen Completes Acquisition of BioVex 2Amgen Completes Acquisition of BioVex 3Amgen Completes Acquisition of BioVex 4Site-wide License for Ariadne's Pathway Studio Renewed by NCI 2
... OmniMD Medical Billing system allows a ... accounting. It is integrated with the ... The system interfaces with electronic clearinghouses ... With a set of reports, it ...
... CPNG3 single liquid stable reagent offers ... single liquid stability to help maximize ... provide quick result turnaround time. The ... CPNG3 reagent provides a long shelf ...
... Infinity Uric Acid single liquid stable ... convenience of single liquid stability to ... error and provide quick result turnaround ... Infinity Uric Acid reagent provides a ...
... Oxidase single liquid stable reagent offers ... single liquid stability to help maximize ... provide quick result turnaround time. The ... Oxidase reagent provides a long shelf ...
Medicine Products: